Minnesota HF3652 limits cost-sharing for epilepsy-related prescription drugs and medical supplies.
Minnesota HF3652 amends the state's health insurance regulations to limit cost-sharing for epilepsy-related prescription drugs and medical supplies. The bill defines "chronic disease" to include epilepsy and specifies "related medical supplies" such as syringes, insulin pens, and epinephrine auto-injectors. Cost-sharing refers to co-payments and coinsurance. This change applies to health plans offered, issued, or renewed on or after January 1, 2027.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.